tiprankstipranks
Trending News
More News >
Advertisement
Advertisement

Guan Chao Holdings’ GROLAND Inc. Gains FDA Approval for U.S. Market Entry

Story Highlights
Guan Chao Holdings’ GROLAND Inc. Gains FDA Approval for U.S. Market Entry

Meet Your ETF AI Analyst

Guan Chao Holdings Limited ( (HK:1872) ) has issued an update.

Guan Chao Holdings Limited announced that its subsidiary, GROLAND Inc., has successfully obtained a Certificate of Cosmetic Product Listing from Zoop Technical Service for its ‘Groland AquaKine Scalp Serum.’ This certification, in compliance with the FDA’s Modernization of Cosmetics Regulation Act of 2022, allows the product to enter the U.S. market. The registration of active compounds XTP-118 and XTP-016 further strengthens the company’s market positioning, enabling safe and compliant product offerings. This milestone not only enhances the company’s ability to promote its brand but also lays the groundwork for future global expansion.

The most recent analyst rating on (HK:1872) stock is a Hold with a HK$5.50 price target. To see the full list of analyst forecasts on Guan Chao Holdings Limited stock, see the HK:1872 Stock Forecast page.

More about Guan Chao Holdings Limited

Guan Chao Holdings Limited, incorporated in the Cayman Islands, operates in the cosmetics industry through its subsidiary GROLAND Inc. The company focuses on developing hair products, with a particular emphasis on compliance with U.S. cosmetic regulations, including ingredient safety and manufacturing practices.

Average Trading Volume: 3,429,584

Technical Sentiment Signal: Buy

Current Market Cap: HK$3.77B

See more insights into 1872 stock on TipRanks’ Stock Analysis page.

Disclaimer & DisclosureReport an Issue

Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App
1